| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Medical Equipment/Supplies/Accessories
|
Compare with Industry peers |
| Website | http://www.centenialindia.com | |
| Financial Indicators | ||
|---|---|---|
| Market Cap | 19.66 Cr. | |
| Earnings per share (EPS) | 2.64 | Trailing Twelve Months Ending 2021-03 |
| Price-Earning Ratio (PE) | 20.44 | Trailing Twelve Months Ending 2021-03 |
| Industry PE | - | Trailing Twelve Months Ending 2021-03 |
| Book Value / Share | 76.19 | Trailing Twelve Months Ending 2021-03 |
| Price to Book Value | 0.71 | Calculated using Price: 53.90 |
| Dividend Yield | 0.00 | Period Ending 2020-03 |
| No. of Shares Subscribed | 0.36 Cr. | 3,648,300 Shares |
| FaceValue | 10 | |
| Company Profile | ||
|
Centenial Surgical Suture Ltd., founded in 1995, manufactures a broad range of quality sterile needled sutures, with state-of-the-art manufacturing and packaging equipment, sophisticated processes designed and operated by Centenial's competent and devoted staff. Centenial Sutures is a combination of Craftmanship, the Latest Production Technology, Strictest Quality Control, Care and Dedication, results in Products of Incomparable Quality. Centenial is a company with a Surgeon's eye for Quality. At Centenial doing business the fair way is their Foremost Concern, by Guaranteeing Courteous, Fair and Honest Service, enough inventory to meet any order size and pricing. Centenial is confident that it can prove its flexibility, capacity and attention for Quality and Consistency in manufacturing world class sutures in India. Centenial has introduced Good Manufacturing Practice into all aspects of production and quality control which includes the maintenance of detailed batch records, a recall system, control of procedures, staff training and a controlled production environment. All products are manufactured to meet US Pharmacopoeia and European Pharmacopoeia and other regulatory requirements. The company proposes to have its range of sutures registered with the US Food and Drug Administration as manufacturer of sterile absorbable and non absorbable sutures. Product range of the company includes: Absorbable Sutures Natural Sutures
Synthetic Sutures
Non Absorbable Sutures
Medical Devices
Awards & Achievements:
|
||
Company Profile
Centenial Surgical Suture Ltd., founded in 1995, manufactures a broad range of quality sterile needled sutures, with state-of-the-art manufacturing and packaging equipment, sophisticated processes designed and operated by Centenial's competent and devoted staff. Centenial Sutures is a combination of Craftmanship, the Latest Production Technology, Strictest Quality Control, Care and Dedication, results in Products of Incomparable Quality. Centenial is a company with a Surgeon's eye for Quality. At Centenial doing business the fair way is their Foremost Concern, by Guaranteeing Courteous, Fair and Honest Service, enough inventory to meet any order size and pricing. Centenial is confident that it can prove its flexibility, capacity and attention for Quality and Consistency in manufacturing world class sutures in India.
Centenial has introduced Good Manufacturing Practice into all aspects of production and quality control which includes the maintenance of detailed batch records, a recall system, control of procedures, staff training and a controlled production environment.
All products are manufactured to meet US Pharmacopoeia and European Pharmacopoeia and other regulatory requirements. The company proposes to have its range of sutures registered with the US Food and Drug Administration as manufacturer of sterile absorbable and non absorbable sutures.
Product range of the company includes:
Absorbable Sutures
Natural Sutures
Synthetic Sutures
Non Absorbable Sutures
Medical Devices
Awards & Achievements:
| 1 Day |
|
-0.09% |
| 1 Week |
|
-0.74% |
| 1 Month |
|
-5.77% |
| 3 Month |
|
+22.78% |
| 6 Month |
|
+3.95% |
| 1 Year |
|
+76.72% |
| 2 Year |
|
+34.75% |
| 5 Year |
|
+4.46% |
| 9 years | 2012-03 | 2013-03 | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | |
| Return on Equity (%) | 11.29 | 10.56 | 10.80 | 10.37 | 7.72 | 7.86 | 6.56 | 7.98 | 4.88 | |
| Return on Capital Employed (%) | 15.80 | 15.38 | 13.36 | 14.22 | 11.74 | 14.02 | 14.84 | 16.75 | 15.11 | |
| Return on Assets (%) | 3.51 | 3.47 | 3.66 | 3.64 | 2.89 | 3.17 | 2.77 | 3.60 | 2.06 |
| Particulars | 9 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Shh. Funds | 16 | 17 | 19 | 21 | 23 | 25 | 26 | 28 | 29 | |
| Non Curr. Liab. | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 10 | |
| Curr. Liab. | 23 | 26 | 27 | 31 | 27 | 28 | 26 | 26 | 31 | |
| Minority Int. | ||||||||||
| Equity & Liab. | 43 | 48 | 50 | 55 | 53 | 56 | 55 | 57 | 69 | |
| Non Curr. Assets | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 5 | 11 | |
| Curr. Assets | 38 | 43 | 45 | 51 | 49 | 52 | 51 | 52 | 58 | |
| Misc. Exp. not W/O | ||||||||||
| Total Assets | 43 | 48 | 50 | 55 | 53 | 56 | 55 | 57 | 69 |
| Particulars | 9 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Net Sales | 52 | 54 | 51 | 52 | 51 | 53 | 53 | 56 | 56 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Income | 53 | 54 | 51 | 52 | 51 | 53 | 53 | 56 | 56 | |
| Total Expenditure | -48 | -49 | -46 | -47 | -47 | -48 | -48 | -51 | -50 | |
| PBIDT | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | |
| Interest | -1 | -2 | -1 | -2 | -2 | -2 | -2 | -2 | -2 | |
| Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | |
| Taxation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
| Exceptional Items | ||||||||||
| PAT | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| Particulars | 9 years | 2012-03 Rs. Cr. | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Cash Fr. Operatn. | 1 | 1 | 0 | 0 | -2 | 2 | 2 | 2 | ||
| Cash Fr. Inv. | -1 | -1 | 0 | 0 | 0 | -2 | -1 | -1 | -1 | |
| Cash Fr. Finan. | 0 | 2 | -1 | 1 | 1 | 2 | -1 | -1 | 0 | |
| Net Change | 0 | 2 | -2 | 1 | -1 | 0 | 0 | -1 | 0 | |
| Cash & Cash Eqvt | 1 | 3 | 1 | 2 | 1 | 1 | 1 | 0 | 1 |
|
Wed, 21 Jul 2021
Shareholding for the Period Ended June 30 2021 Centenial Surgical Suture Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here |
|
Tue, 13 Jul 2021
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of the SEBI (Depository and Participants) Regulations 2018 for the quarter ended June 30 2021 received from M/s. Purva Shareregistry (I) Private Limited Mumbai MAHARASHTRA SEBI Registration No. : INR000001112 Registrar & Transfer Agent of our Company. This is for your information and record. |
|
Tue, 13 Jul 2021
Disclosures Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements [LODR]) Regulations 2015. Disclosures of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements [LODR]) Regulations 2015 for the half year and year ended on March 31 2021 |
| Thu, 29 Jul 2021 |
Stock Outperforming Sectoral Index in both 1 Week and 3 Month
|
Decreasing Relative Strength - Benchmark index
|
Decreasing Relative Strength - Sectoral index
|
Closing Near 50 EMA
|
| Wed, 28 Jul 2021 |
Strongly Outperforming Benchmark Index
|
Equities
M.F.
Sectors